These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2346 related items for PubMed ID: 27899297

  • 1. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
    Notarpaolo A, Layese R, Magistri P, Gambato M, Colledan M, Magini G, Miglioresi L, Vitale A, Vennarecci G, Ambrosio CD, Burra P, Di Benedetto F, Fagiuoli S, Colasanti M, Maria Ettorre G, Andreoli A, Cillo U, Laurent A, Katsahian S, Audureau E, Roudot-Thoraval F, Duvoux C.
    J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
    [Abstract] [Full Text] [Related]

  • 2. Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria.
    Duvoux C, Roudot-Thoraval F, Decaens T, Pessione F, Badran H, Piardi T, Francoz C, Compagnon P, Vanlemmens C, Dumortier J, Dharancy S, Gugenheim J, Bernard PH, Adam R, Radenne S, Muscari F, Conti F, Hardwigsen J, Pageaux GP, Chazouillères O, Salame E, Hilleret MN, Lebray P, Abergel A, Debette-Gratien M, Kluger MD, Mallat A, Azoulay D, Cherqui D, Liver Transplantation French Study Group.
    Gastroenterology; 2012 Oct; 143(4):986-94.e3; quiz e14-5. PubMed ID: 22750200
    [Abstract] [Full Text] [Related]

  • 3. Risk factors of hepatocellular carcinoma recurrence after liver transplantation: accuracy of the alpha-fetoprotein model in a single-center experience.
    Varona MA, Soriano A, Aguirre-Jaime A, Garrido S, Oton E, Diaz D, Portero J, Bravo P, Barrera MA, Perera A.
    Transplant Proc; 2015 Oct; 47(1):84-9. PubMed ID: 25645778
    [Abstract] [Full Text] [Related]

  • 4. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.
    Franssen B, Alshebeeb K, Tabrizian P, Marti J, Pierobon ES, Lubezky N, Roayaie S, Florman S, Schwartz ME.
    Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of Patients With Hepatocellular Carcinomas That Do Not Produce α-Fetoprotein.
    Agopian VG, Harlander-Locke MP, Markovic D, Zarrinpar A, Kaldas FM, Cheng EY, Yersiz H, Farmer DG, Hiatt JR, Busuttil RW.
    JAMA Surg; 2017 Jan 01; 152(1):55-64. PubMed ID: 27706479
    [Abstract] [Full Text] [Related]

  • 6. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M, Tan W, Yang X, Zhuo J, Lin Z, Cen B, Lian Z, Li H, Lu D, Wei X, Zheng S, Xu X.
    Cancer Biomark; 2020 Jan 01; 29(2):197-206. PubMed ID: 32623388
    [Abstract] [Full Text] [Related]

  • 7. Liver transplantation for hepatocellular carcinoma: evaluation of the alpha-fetoprotein model in a multicenter cohort from Latin America.
    Piñero F, Tisi Baña M, de Ataide EC, Hoyos Duque S, Marciano S, Varón A, Anders M, Zerega A, Menéndez J, Zapata R, Muñoz L, Padilla Machaca M, Soza A, McCormack L, Poniachik J, Podestá LG, Gadano A, Boin IS, Duvoux C, Silva M, Latin American Liver Research, Education and Awareness Network (LALREAN).
    Liver Int; 2016 Nov 01; 36(11):1657-1667. PubMed ID: 27169841
    [Abstract] [Full Text] [Related]

  • 8. Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma.
    Mazzaferro V, Sposito C, Zhou J, Pinna AD, De Carlis L, Fan J, Cescon M, Di Sandro S, Yi-Feng H, Lauterio A, Bongini M, Cucchetti A.
    Gastroenterology; 2018 Jan 01; 154(1):128-139. PubMed ID: 28989060
    [Abstract] [Full Text] [Related]

  • 9. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M, Mizuguchi T, Nishidate T, Okita K, Ishii M, Ota S, Ueki T, Akizuki E, Hirata K.
    World J Gastroenterol; 2015 Apr 28; 21(16):4933-45. PubMed ID: 25945007
    [Abstract] [Full Text] [Related]

  • 10. Alpha-Fetoprotein Slope >7.5 ng/mL per Month Predicts Microvascular Invasion and Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma.
    Giard JM, Mehta N, Dodge JL, Roberts JP, Yao FY.
    Transplantation; 2018 May 28; 102(5):816-822. PubMed ID: 29505494
    [Abstract] [Full Text] [Related]

  • 11. Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria.
    Hameed B, Mehta N, Sapisochin G, Roberts JP, Yao FY.
    Liver Transpl; 2014 Aug 28; 20(8):945-51. PubMed ID: 24797281
    [Abstract] [Full Text] [Related]

  • 12. Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma.
    Halazun KJ, Rosenblatt RE, Mehta N, Lai Q, Hajifathalian K, Gorgen A, Brar G, Sasaki K, Doyle MBM, Tabrizian P, Agopian VG, Najjar M, Ivanics T, Samstein B, Brown RS, Emond JC, Yao F, Lerut J, Rossi M, Mennini G, Iesari S, Finkenstedt A, Schaefer B, Mittler J, Hoppe-Lotichius M, Quintini C, Aucejo F, Chapman W, Sapisochin G.
    JAMA Surg; 2021 Jun 01; 156(6):559-567. PubMed ID: 33950167
    [Abstract] [Full Text] [Related]

  • 13. Total tumor volume and alpha-fetoprotein for selection of transplant candidates with hepatocellular carcinoma: A prospective validation.
    Toso C, Meeberg G, Hernandez-Alejandro R, Dufour JF, Marotta P, Majno P, Kneteman NM.
    Hepatology; 2015 Jul 01; 62(1):158-65. PubMed ID: 25777590
    [Abstract] [Full Text] [Related]

  • 14. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG, Harlander-Locke M, Zarrinpar A, Kaldas FM, Farmer DG, Yersiz H, Finn RS, Tong M, Hiatt JR, Busuttil RW.
    J Am Coll Surg; 2015 Apr 01; 220(4):416-27. PubMed ID: 25690672
    [Abstract] [Full Text] [Related]

  • 15. Alpha-fetoprotein-adjusted-to-HCC-size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinoma.
    Meischl T, Rasoul-Rockenschaub S, Győri G, Scheiner B, Trauner M, Soliman T, Berlakovich G, Pinter M.
    United European Gastroenterol J; 2021 Mar 01; 9(2):209-219. PubMed ID: 32741316
    [Abstract] [Full Text] [Related]

  • 16. Prediction of Early Recurrence of Hepatocellular Carcinoma in Patients with Cirrhosis Who Had Received Deceased Donor Liver Transplantation: A Multicenter Study.
    Al-Ameri AAM, Wei X, Liu P, Lin L, Shao Z, Xie H, Zhou L, Zheng S, Xu X.
    Ann Transplant; 2019 Aug 20; 24():489-498. PubMed ID: 31427563
    [Abstract] [Full Text] [Related]

  • 17. α-Fetoprotein is a potential survival predictor in hepatocellular carcinoma patients with hepatitis B selected for liver transplantation.
    Zhang Q, Shang L, Zang Y, Chen X, Zhang L, Wang Y, Wang L, Liu Y, Mao S, Shen Z.
    Eur J Gastroenterol Hepatol; 2014 May 20; 26(5):544-52. PubMed ID: 24614696
    [Abstract] [Full Text] [Related]

  • 18. Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
    Piros L, Fehérvári I, Görög D, Nemes B, Szabó J, Gerlei Z, Végső G, Kóbori L, Máthé Z.
    Transplant Proc; 2015 Sep 20; 47(7):2201-6. PubMed ID: 26361680
    [Abstract] [Full Text] [Related]

  • 19. Utility of alpha-fetoprotein (AFP) in the screening of patients with virus-related chronic liver disease: does different viral etiology influence AFP levels in HCC? A study in 350 western patients.
    Cedrone A, Covino M, Caturelli E, Pompili M, Lorenzelli G, Villani MR, Valle D, Sperandeo M, Rapaccini GL, Gasbarrini G.
    Hepatogastroenterology; 2000 Sep 20; 47(36):1654-8. PubMed ID: 11149026
    [Abstract] [Full Text] [Related]

  • 20. Combination of morphologic criteria and α-fetoprotein in selection of patients with hepatocellular carcinoma for liver transplantation minimizes the problem of posttransplant tumor recurrence.
    Grąt M, Kornasiewicz O, Lewandowski Z, Hołówko W, Grąt K, Kobryń K, Patkowski W, Zieniewicz K, Krawczyk M.
    World J Surg; 2014 Oct 20; 38(10):2698-707. PubMed ID: 24858191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 118.